Search by Drug Name or NDC

    NDC 55111-0447-14 Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1 Details

    Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1

    Fexofenadine HCl and Pseudoephedrine HCI is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Dr. Reddy's Laboratories Limited. The primary component is FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 55111-0447
    Product ID 55111-447_525f547d-5d98-ecff-8eb4-13ceb0407e4d
    Associated GPIs 43993002687420
    GCN Sequence Number 036868
    GCN Sequence Number Description fexofenadine/pseudoephedrine TAB ER 12H 60MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 63565
    HICL Sequence Number 016846
    HICL Sequence Number Description FEXOFENADINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Fexofenadine HCl and Pseudoephedrine HCI
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fexofenadine HCl and Pseudoephedrine HCI
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 60; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name Dr. Reddy's Laboratories Limited
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076667
    Listing Certified Through 2024-12-31

    Package

    NDC 55111-0447-14 (55111044714)

    NDC Package Code 55111-447-14
    Billing NDC 55111044714
    Package 4 BLISTER PACK in 1 CARTON (55111-447-14) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (55111-447-07)
    Marketing Start Date 2014-11-18
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.47685
    Pricing Unit EA
    Effective Date 2023-08-23
    NDC Description FEXOFENADINE-PSE ER 60-120 TAB
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL 728632be-7e5c-2d06-4c95-bc8ecc9be2ec Details

    Revised: 10/2015